NVIV Company Profile and Key Details
InVivo Therapeutics Holdings Corp.
NVIV Stock Price Chart
Stock Price Today
InVivo Therapeutics Holdings Corporation (NVIV) stock declined over -34.28%, trading at $0.32 on NASDAQ, down from the previous close of $0.49. The stock opened at $0.41, fluctuating between $0.30 and $0.41 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts.
Company Information
| Employees | 6 |
| Beta | 0.66 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) stock price is $0.32 in the last trading session. During the trading session, NVIV stock reached the peak price of $0.41 while $0.30 was the lowest point it dropped to. The percentage change in NVIV stock occurred in the recent session was -34.28% while the dollar amount for the price change in NVIV stock was -$0.17.
The NASDAQ listed NVIV is part of Biotechnology industry that operates in the broader Healthcare sector. InVivo Therapeutics Holdings Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Richard C. Christopher
Chief Financial Officer & Treasurer
Dr. Joseph Philip Vacanti
Co-Founder
Dr. Louis Vaickus FACP, M.D.
Consultant
Mr. Jerome Gangitano
Senior Vice President of Operations
Dr. Richard M. Toselli
Pres, Chief Executive Officer, Chief Medical Officer & Director
Ms. Heather M. Hamel J.D.
Chief Legal Officer & Gen. Counsel
NVIV's closing price is 45.77% higher than its 52-week low of $0.22 where as its distance from 52-week high of $2.40 is -86.64%.
Number of NVIV employees currently stands at 6.
Official Website of NVIV is: https://www.invivotherapeutics.com
NVIV could be contacted at phone 617 863 5500 and can also be accessed through its website. NVIV operates from One Kendall Square, Cambridge, MA 02139, United States.
NVIV stock volume for the day was 1.61M shares. The average number of NVIV shares traded daily for last 3 months was 3.77M.
The market value of NVIV currently stands at $995.92K with its latest stock price at $0.32 and 3.11M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com